MenüForum-NavigationForumMitgliederAnmeldenRegistrierenForum-Breadcrumbs - Du bist hier:ForumFlohmarkt: AllgemeineskmqacaAntwortenAntworten: kmqaca <blockquote><div class="quotetitle">Zitat von Gast am 24. März 2026, 14:19 Uhr</div>[url=https://www.sciencedirect.com/science/article/abs/pii/037811199400784P ]Zoya Demidenko[/url]: Scholar in Tumor Science [url=https://pubmed.ncbi.nlm.nih.gov/22228887/ ]Zoya Demidenko[/url] is a prominent scientist affiliated with the Department of Cell Stress Biology at Roswell Park Cancer Institute in Buffalo, New York. Earlier, she was employed at the National Institutes of Health and New York Medical College, establishing a strong background in clinical research. Demidenko's scientific contributions spans several pivotal areas, encompassing the PI3K/AKT/mTOR signaling pathway, cell cycle management, cell senescence, and cancer biology. Currently, she has co-authored more than 46 academic papers, which have garnered over 4,100 citations — a testament to the significance of her research. One of her key achievements involves understanding the mechanisms of cellular senescence. Her studies revealed that when the cell cycle is blocked yet cellular growth continues, cells enter senescence. Significantly, [url=https://scholargps.com/scholars/59798749410547/zoya-n-demidenko ]Zoya Demidenko[/url] established that this shift is inhibited by medication using agents such as mTOR inhibitors. [url=https://www.instagram.com/zoyamonros/ ]Zoya Demidenko[/url] has additionally brought greatly to cancer treatment investigation, notably in the domain of cyclotherapy — a approach designed to safeguarding non-cancerous tissue from chemotherapy whilst leaving malignant cells vulnerable. This strategy holds major promise for lowering the adverse effects of cancer treatment. Throughout her professional journey, Demidenko has worked with top investigators worldwide, among them Dr. Mikhail Blagosklonny. Her publications can be found in prestigious publications such as Oncotarget, Cell Cycle, Aging (Albany NY), and Oncogene. With an h-index of 33, [url=https://journals.plos.org/plosone/article/authors?id=10.1371/journal.pone.0026126 ]Zoya Demidenko[/url] ranks as a highly impactful contributor in current oncological science, whose results keep to influence our understanding of the way cells grow old, respond to therapy, and how cancer may be more effectively targeted. https://www.instagram.com/hibou_sova/ </blockquote><br> Abbrechen
